Canada Life’s Lifecore Biomedical LFCR Stock Holding History

Canada Life’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,380	Closed	-$13K	–	2533
2021 Q3	$13K	Hold	1,380	–	–	﹤0.01%	2490
2021 Q2	$16K	Hold	1,380	–	–	﹤0.01%	2515
2021 Q1	$14K	Hold	1,380	–	–	﹤0.01%	2542
2020 Q4	$15K	Hold	1,380	–	–	﹤0.01%	2571
2020 Q3	$13K	Hold	1,380	–	–	﹤0.01%	2504
2020 Q2	$11K	Hold	1,380	–	–	﹤0.01%	2563
2020 Q1	$12K	Hold	1,380	–	–	﹤0.01%	2475
2019 Q4	$15K	Hold	1,380	–	–	﹤0.01%	2553
2019 Q3	$15K	Sell	1,380 -1,220	-47%	-$13.3K	﹤0.01%	1088
2019 Q2	$24K	Hold	2,600	–	–	﹤0.01%	2566
2019 Q1	$32K	Hold	2,600	–	–	﹤0.01%	2324
2018 Q4	$30K	Hold	2,600	–	–	﹤0.01%	2491
2018 Q3	$37K	Hold	2,600	–	–	﹤0.01%	2443
2018 Q2	$39K	Hold	2,600	–	–	﹤0.01%	2452
2018 Q1	$34K	Hold	2,600	–	–	﹤0.01%	2439
2017 Q4	$33K	Hold	2,600	–	–	﹤0.01%	2440
2017 Q3	$34K	Hold	2,600	–	–	﹤0.01%	2415
2017 Q2	$38K	Hold	2,600	–	–	﹤0.01%	2398
2017 Q1	$31K	Hold	2,600	–	–	﹤0.01%	2404
2016 Q4	$36K	Sell	2,600 -5,700	-69%	-$79K	﹤0.01%	2395
2016 Q3	$111K	Hold	8,300	–	–	﹤0.01%	2095
2016 Q2	$89K	Hold	8,300	–	–	﹤0.01%	2143
2016 Q1	$87K	Hold	8,300	–	–	﹤0.01%	1881
2015 Q4	$98K	Hold	8,300	–	–	﹤0.01%	1777
2015 Q3	$97K	Sell	8,300 -104	-1%	-$1.38K	﹤0.01%	1726
2015 Q2	$122K	Hold	8,404	–	–	﹤0.01%	1720
2015 Q1	$116K	Buy	8,404 +104	+1%	+$1.44K	﹤0.01%	1705
2014 Q4	$114K	Hold	8,300	–	–	﹤0.01%	1668
2014 Q3	$102K	Hold	8,300	–	–	﹤0.01%	1671
2014 Q2	$103K	Buy	+8,300	New	+$97.7K	﹤0.01%	1562

Other funds holding LFCR

Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return

LPAM

Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ICM

ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return

CSC

Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Canada Life's LFCR Position: Q4 2021 in Review

Canada Life sold out of Lifecore Biomedical (LFCR) in Q4 2021, closing a stake of 1,380 shares — an estimated $13K sold.

Canada Life first reported a position in LFCR in Q2 2014 and held it in 30 quarters. The position peaked at $122K in Q2 2015. 98 funds tracked by Wall St. Rank hold LFCR as of Q4 2021.

Canada Life reported no remaining Lifecore Biomedical position as of Q4 2021 after selling out during the quarter.
Canada Life sold 1,380 Lifecore Biomedical shares in Q4 2021, an estimated $13K.
Canada Life first reported a position in Lifecore Biomedical in Q2 2014 and held it in 30 quarters.
Canada Life's Lifecore Biomedical position peaked at $122K in Q2 2015.
98 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q4 2021.

Based on Canada Life's 13F filing for Q4 2021, filed 14 Feb 2022.